Alexey L. Margolin, Chief Scientific Officer at Altus Pharmaceuticals Inc. (ALTU), sold 10,900 shares at $11.55 ($126K) on 2007-07-18, disclosed to the SEC on 2007-07-20.
Scheduled sale ($126k) by Chief Scientific Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| ALTU | SELL | 2007-03-19 | $47K | — | Filing → |
| ALTU | SELL | 2007-03-06 | $44K | — | Filing → |
| ALTU | SELL | 2007-02-21 | $109K | — | Filing → |